01 1Activase
02 6Activase/TNKase
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 1,372
2018 Revenue in Millions : 1,323
Growth (%) : 4
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 1,472
2019 Revenue in Millions : 1,484
Growth (%) : -1
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 1,412
2020 Revenue in Millions : 1,400
Growth (%) : -1
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 1,287
2021 Revenue in Millions : 1,412
Growth (%) : -9
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 1,361
2022 Revenue in Millions : 1,287
Growth (%) : 0
Main Therapeutic Indication : Cardiovascular
Currency : USD
2014 Revenue in Millions : 9.40%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Cardiovascular
Currency : USD
2015 Revenue in Millions : 754
2014 Revenue in Millions : 944
Growth (%) : 25%
LOOKING FOR A SUPPLIER?
